APA
Bakker W. A. M., Thomassen Y. E., van't Oever A. G., Westdijk J., van Oijen M. G. C. T., Sundermann L. C., van't Veld P., Sleeman E., van Nimwegen F. W., Hamidi A., Kersten G. F. A., van den Heuvel N., Hendriks J. T. & van der Pol L. A. (20120118). Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. : Vaccine.
Chicago
Bakker Wilfried A M, Thomassen Yvonne E, van't Oever Aart G, Westdijk Janny, van Oijen Monique G C T, Sundermann Lars C, van't Veld Peter, Sleeman Eelco, van Nimwegen Fred W, Hamidi Ahd, Kersten Gideon F A, van den Heuvel Nico, Hendriks Jan T and van der Pol Leo A. 20120118. Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. : Vaccine.
Harvard
Bakker W. A. M., Thomassen Y. E., van't Oever A. G., Westdijk J., van Oijen M. G. C. T., Sundermann L. C., van't Veld P., Sleeman E., van Nimwegen F. W., Hamidi A., Kersten G. F. A., van den Heuvel N., Hendriks J. T. and van der Pol L. A. (20120118). Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. : Vaccine.
MLA
Bakker Wilfried A M, Thomassen Yvonne E, van't Oever Aart G, Westdijk Janny, van Oijen Monique G C T, Sundermann Lars C, van't Veld Peter, Sleeman Eelco, van Nimwegen Fred W, Hamidi Ahd, Kersten Gideon F A, van den Heuvel Nico, Hendriks Jan T and van der Pol Leo A. Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. : Vaccine. 20120118.